Synthesis and Hepatitis C Antiviral Activity of 1-Aminobenzyl-1<i>H</i>-indazole-3-carboxamide Analogues
作者:Jing-Jing Shi、Fei-Hong Ji、Pei-Lan He、Ya-xi Yang、Wei Tang、Jian-Ping Zuo、Yuan-Chao Li
DOI:10.1002/cmdc.201300083
日期:2013.5
Fighting HCV: Two potent antiviral analogues were developed from a previously identified lead as novel agents against hepatitis C virus. Their potency and selectivity (5 n: IC50=0.013 μM and EC50=0.018 μM; 5 t: IC50=0.007 μM and EC50=0.024 μM) make them good candidates for further development as antiviral agents.
对抗HCV:从先前确定的铅开发出了两种有效的抗病毒类似物,它们是对抗丙型肝炎病毒的新型药物。它们的效力和选择性(5 N:IC 50 = 0.013μ中号和EC 50 = 0.018μ中号; 5吨:IC 50 = 0.007μ中号和EC 50 = 0.024μ中号)使它们用于进一步开发作为抗病毒剂的良好候选者。